北美四肢癱瘓護理設備市場－行業分析、規模、佔有率、成長、趨勢、預測（2031）- 依產品、依適應症、依最終用戶、依國家/地區

由於脊髓損傷盛行率不斷上升以及技術不斷進步，北美四肢癱瘓護理設備的市場規模預計將大幅成長。該市場估計到2024年將達到5.0686億美元，到2031年將成長到7.41億美元，並以5.6%的穩定年複合成長率（CAGR）擴張。該成長是由對醫院病床和專門醫療設備的強勁需求推動的，這些設備目的是改善四肢癱瘓患者的活動能力、舒適度和整體生活品質。

市場動態支持市場成長軌跡的是北美每年報告的脊髓損傷病例數量不斷增加。根據國家脊髓損傷統計中心的資料，每年都會記錄數千例新的脊髓損傷病例，需要先進的醫療解決方案，例如機械手臂系統、義肢和其他輔助裝置。這些創新滿足了四肢癱瘓患者的獨特需求，並促進了更具包容性和協作性的醫療環境。

銷售分析與市場展望 過去五年，北美四肢癱瘓護理設備市場穩步擴張，反映出對專業護理的需求不斷成長。2016年至2020年的銷售分析強調，在脊髓損傷盛行率上升和醫療技術進步等因素的推動下，這些設備的使用量持續增加。預計市場將繼續呈上升趨勢，重點是提供改善患者治療效果的尖端解決方案。

本報告調查了北美四肢癱瘓護理設備市場，並依產品、適應症、最終用戶、國家/地區以及進入該市場的公司的競爭趨勢提供了市場概述。

目錄

第1章 執行摘要

第2章 市場概述

• 市場定義與細分
• 市場動態
• 用於支援和護理的新技術
• 監管場景
• 價值鏈分析
• 波特五力分析
• 新冠肺炎（COVID-19）影響分析
• 經濟概況
• PESTLE分析

第3章 價格分析，2018-2024

第4章 北美四肢癱瘓護理設備市場前景，2018-2031

• 北美四肢癱瘓護理設備市場前景，依產品，價值（十億美元），數量（台），2018-2031年
• 北美四肢癱瘓護理設備市場前景，依適應症分類，價值（十億美元），2018-2031年
• 北美四肢癱瘓護理設備市場前景，依最終用戶，價值（十億美元），2018-2031年
• 北美四肢癱瘓護理設備市場前景，依國家，價值（十億美元），數量（台），2018-2031年

第5章 美國四肢癱瘓護理設備市場前景，2018-2031

第6章 加拿大四肢癱瘓護理設備市場前景，2018-2031

第7章 競爭態勢

• 2024年公司市佔率分析
• 競爭對手儀表板
• 公司簡介
  • ReWalk Robotics
  • Ekso Bionics
  • Indego
  • Rex Bionics Ltd.
  • Caltech
  • Ossur
  • Steeper Inc
  • Boston Scientific Corporation
  • Medtronic Plc
  • Ottobock
  • RGK Wheelchair

第8章 附錄

The North American quadriplegia care devices market is poised for substantial growth, driven by the increasing prevalence of spinal cord injuries and ongoing technological advancements. Projected by Fairfield Market Research, the market is expected to reach $506.86 million by 2024, growing to $741 million by 2031, reflecting a steady compound annual growth rate (CAGR) of 5.6%. This growth is fueled by robust demand for hospital beds and specialized medical equipment tailored to enhance mobility, comfort, and overall quality of life for quadriplegic patients.

Market Dynamics The market's growth trajectory is supported by the increasing number of spinal cord injury cases reported annually in North America. According to data from the National Spinal Cord Injury Statistical Center, thousands of new spinal cord injury cases are recorded each year, necessitating advanced medical solutions such as robotic arm systems, prosthetics, and other assistive devices. These innovations cater to the unique needs of quadriplegic patients, fostering a more inclusive and supportive healthcare environment.

Sales Analysis and Market Outlook Over the past five years, the North American market for quadriplegia care devices expanded at a steady pace, reflecting the growing demand for specialized care. The sales analysis from 2016 to 2020 highlights a consistent increase in the adoption of these devices, driven by factors such as the rising prevalence of spinal cord injuries and advancements in medical technology. Looking ahead, the market is expected to continue its upward trajectory, with a focus on delivering cutting-edge solutions that improve patient outcomes.

Technological Advancements Driving Market Growth Technological innovations are at the heart of the market's growth, with recent developments in computer science, robotics, artificial intelligence, and sensor technology broadening the range of applications for quadriplegia care devices. Powered wheelchairs, for example, have revolutionized mobility for quadriplegic patients by incorporating control and navigational intelligence. These advanced devices are designed to enhance efficiency, reduce stress, and offer greater flexibility, thereby improving the overall quality of life for users.

Product Innovations and Market Opportunities The market is witnessing a surge in product innovations aimed at addressing the specific needs of quadriplegic patients. For instance, the introduction of new orthopaedic braces with hot and cold therapy features has significantly improved patient comfort and treatment outcomes. These dual-feature braces are set to dominate the market, replacing conventional systems and driving future growth.

Key Opportunities for Manufacturers The increasing prevalence of spinal cord injuries and the rapid pace of technological advancements present significant opportunities for quadriplegia care device manufacturers. The widespread acceptance and adoption of these advanced devices, driven by rigorous research and early product launches, are creating a fertile ground for market expansion. Additionally, the efforts of non-governmental organizations (NGOs) to raise awareness about conditions such as osteoporosis are expected to further boost the demand for quadriplegia care solutions.

Challenges and Restraints Despite the promising growth prospects, the market faces several challenges. High costs associated with advanced braces and the regulatory hurdles imposed by agencies such as the FDA are significant barriers to market entry for new players. Additionally, the availability of second-hand quadriplegia care devices, often donated or resold, poses a challenge to the growth of new product sales. However, these challenges also present opportunities for manufacturers to innovate and develop cost-effective solutions that comply with regulatory standards.

Country-wise Insights The U.S. dominates the North American quadriplegia care devices market, driven by a high incidence of quadriplegia and a strong healthcare infrastructure. The country's market share is bolstered by the consolidation among healthcare providers and the widespread adoption of advanced devices to reduce healthcare costs. Meanwhile, Canada, with a notable incidence of spinal cord injuries, represents a growing market for quadriplegia care devices. The increasing number of spinal cord injury cases in Canada is expected to drive demand for advanced treatment solutions.

Product and Indication Analysis Hospital beds are among the most in-demand quadriplegia care products, accounting for a significant market share. These technologically-advanced beds, designed specifically for paraplegic and quadriplegic care, provide enhanced comfort and improved health outcomes. In terms of indications, sports injuries and car accidents are the most common causes of incomplete quadriplegia, driving the demand for specialized care devices.

Competitive Analysis

• ReWalk Robotics
• Ekso Bionics
• Indego (Parker Hannifin Corporation)
• Rex Bionics Ltd.
• Caltech
• Ossur
• Steeper, Inc.
• Boston Scientific corporation
• Medtronic Plc.
• Ottobock
• RGK Wheelchairs
• Rifton Equipment
• Allard USA, Inc.
• Fillauer LLC
• College Park Industries
• Mobius Bionics.
• Parker Hannifin
• Nevro
• ProBed Medical Technologies Inc.
• BLUE CHIP MEDICAL
• Restorative Therapies
• MYOLYN, LLC

Key Segments in North America Quadriplegia Care Devices Industry Survey

North America Quadriplegia Care Devices Market by Product:

• Stimulation Devices
  • Spinal Cord Stimulators
  • Functional Electrical Stimulation (FES) Systems
• Assistive Devices
  • Exoskeletons
  • Robotic Arm Systems
  • Prosthetics

§ Upper Limb Prosthetics

§ Lower Limb Prosthetics

• Mobility Devices
  • Wheelchairs
  • Crutches & Walkers
  • Gait Trainers
• Hospital Beds
• Transfer Bench and Boards
• Braces & Supports
• Orthopaedic Splints
• Others Supportive Devices

North America Quadriplegia Care Devices Market by Indication:

• Incomplete Quadriplegia
• Complete Quadriplegia

North America Quadriplegia Care Devices Market by End User:

• Rehabilitation Centres
• Assistive Living Facilities
• Long-term Care Centers
• Home Care Settings

North America Quadriplegia Care Devices Market by Country:

• U.S Quadriplegia Care Devices Market
• Canada Quadriplegia Care Devices Market

Table of Contents

1. Executive Summary

• 1.1. North America Quadriplegia Care Devices Market Snapshot
• 1.2. Future Projections
• 1.3. Key Market Trends
• 1.4. Regional Snapshot, by Value and Volume, 2024
• 1.5. Analyst Recommendations

2. Market Overview

• 2.1. Market Definitions and Segmentations
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Market Opportunities
• 2.3. Emerging Technologies for Support & Care
• 2.4. Regulatory Scenario
• 2.5. Value Chain Analysis
• 2.6. Porter's Five Forces Analysis
• 2.7. COVID-19 Impact Analysis
  • 2.7.1. Supply
  • 2.7.2. Demand
• 2.8. Economic Overview
  • 2.8.1. World Economic Projections
• 2.9. PESTLE Analysis

3. Price Analysis, 2018 - 2024

• 3.1. North America Average Price Analysis, by Product, US$ Per Unit, 2018 - 2024
• 3.2. Prominent Factor Affecting Quadriplegia Care Devices Prices
• 3.3. North America Average Price Analysis, by Region, US$ Per Unit

4. North America Quadriplegia Care Devices Market Outlook, 2018 - 2031

• 4.1. North America Quadriplegia Care Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  • 4.1.1. Key Highlights
    • 4.1.1.1. Stimulation Devices
    • 4.1.1.2. Assistive Devices
    • 4.1.1.3. Mobility Devices
    • 4.1.1.4. Hospital Beds
    • 4.1.1.5. Transfer Bench and Boards
    • 4.1.1.6. Braces & Supports
    • 4.1.1.7. Orthopaedic Splints
    • 4.1.1.8. Others Supportive Devices
• 4.2. North America Quadriplegia Care Devices Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
  • 4.2.1. Key Highlights
    • 4.2.1.1. Incomplete Quadriplegia
    • 4.2.1.2. Complete Quadriplegia
• 4.3. North America Quadriplegia Care Devices Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
  • 4.3.1. Key Highlights
    • 4.3.1.1. Rehabilitation Centres
    • 4.3.1.2. Assistive Living Facilities
    • 4.3.1.3. Long-term Care Centres
    • 4.3.1.4. Home Care Settings
• 4.4. North America Quadriplegia Care Devices Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
  • 4.4.1. Key Highlights
    • 4.4.1.1. U.S.
    • 4.4.1.2. Canada

5. U.S. Quadriplegia Care Devices Market Outlook, 2018 - 2031

• 5.1. U.S. Quadriplegia Care Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  • 5.1.1. Key Highlights
    • 5.1.1.1. Stimulation Devices
    • 5.1.1.2. Assistive Devices
    • 5.1.1.3. Mobility Devices
    • 5.1.1.4. Hospital Beds
    • 5.1.1.5. Transfer Bench and Boards
    • 5.1.1.6. Braces & Supports
    • 5.1.1.7. Orthopaedic Splints
    • 5.1.1.8. Others Supportive Devices
• 5.2. U.S. Quadriplegia Care Devices Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
  • 5.2.1. Key Highlights
    • 5.2.1.1. Incomplete Quadriplegia
    • 5.2.1.2. Complete Quadriplegia
• 5.3. U.S. Quadriplegia Care Devices Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
  • 5.3.1. Key Highlights
    • 5.3.1.1. Rehabilitation Centres
    • 5.3.1.2. Assistive Living Facilities
    • 5.3.1.3. Long-term Care Centres
    • 5.3.1.4. Home Care Settings
  • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Canada Quadriplegia Care Devices Market Outlook, 2018 - 2031

• 6.1. Canada Quadriplegia Care Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
  • 6.1.1. Key Highlights
    • 6.1.1.1. Stimulation Devices
    • 6.1.1.2. Assistive Devices
    • 6.1.1.3. Mobility Devices
    • 6.1.1.4. Hospital Beds
    • 6.1.1.5. Transfer Bench and Boards
    • 6.1.1.6. Braces & Supports
    • 6.1.1.7. Orthopaedic Splints
    • 6.1.1.8. Others Supportive Devices
• 6.2. Canada Quadriplegia Care Devices Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
  • 6.2.1. Key Highlights
    • 6.2.1.1. Incomplete Quadriplegia
    • 6.2.1.2. Complete Quadriplegia
• 6.3. Canada Quadriplegia Care Devices Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
  • 6.3.1. Key Highlights
    • 6.3.1.1. Rehabilitation Centres
    • 6.3.1.2. Assistive Living Facilities
    • 6.3.1.3. Long-term Care Centres
    • 6.3.1.4. Home Care Settings
  • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Competitive Landscape

• 7.1. Company Market Share Analysis, 2024
• 7.2. Competitive Dashboard
• 7.3. Company Profiles
  • 7.3.1. ReWalk Robotics
    • 7.3.1.1. Company Overview
    • 7.3.1.2. Product Portfolio
    • 7.3.1.3. Financial Overview
    • 7.3.1.4. Business Strategies and Development
  • 7.3.2. Ekso Bionics
    • 7.3.2.1. Company Overview
    • 7.3.2.2. Product Portfolio
    • 7.3.2.3. Financial Overview
    • 7.3.2.4. Business Strategies and Development
  • 7.3.3. Indego (Parker Hannifin Corporation)
    • 7.3.3.1. Company Overview
    • 7.3.3.2. Product Portfolio
    • 7.3.3.3. Financial Overview
    • 7.3.3.4. Business Strategies and Development
  • 7.3.4. Rex Bionics Ltd.
    • 7.3.4.1. Company Overview
    • 7.3.4.2. Product Portfolio
    • 7.3.4.3. Financial Overview
    • 7.3.4.4. Business Strategies and Development
  • 7.3.5. Caltech
    • 7.3.5.1. Company Overview
    • 7.3.5.2. Product Portfolio
    • 7.3.5.3. Financial Overview
    • 7.3.5.4. Business Strategies and Development
  • 7.3.6. Ossur
    • 7.3.6.1. Company Overview
    • 7.3.6.2. Product Portfolio
    • 7.3.6.3. Financial Overview
    • 7.3.6.4. Business Strategies and Development
  • 7.3.7. Steeper Inc
    • 7.3.7.1. Company Overview
    • 7.3.7.2. Product Portfolio
    • 7.3.7.3. Financial Overview
    • 7.3.7.4. Business Strategies and Development
  • 7.3.8. Boston Scientific Corporation
    • 7.3.8.1. Company Overview
    • 7.3.8.2. Product Portfolio
    • 7.3.8.3. Financial Overview
    • 7.3.8.4. Business Strategies and Development
  • 7.3.9. Medtronic Plc
    • 7.3.9.1. Company Overview
    • 7.3.9.2. Product Portfolio
    • 7.3.9.3. Financial Overview
    • 7.3.9.4. Business Strategies and Development
  • 7.3.10. Ottobock
    • 7.3.10.1. Company Overview
    • 7.3.10.2. Product Portfolio
    • 7.3.10.3. Financial Overview
    • 7.3.10.4. Business Strategies and Development
  • 7.3.11. RGK Wheelchair
    • 7.3.11.1. Company Overview
    • 7.3.11.2. Product Portfolio
    • 7.3.11.3. Financial Overview
    • 7.3.11.4. Business Strategies and Development

8. Appendix

• 8.1. Research Methodology
• 8.2. Report Assumptions
• 8.3. Acronyms and Abbreviations